C12N 9/2494
Mannan endo-1,4-beta-mannosidase , i.e. endo-beta-mannanase
Official title: {Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase}
C12N9/2494 (Mannan endo-1,4-beta-mannosidase , i.e. endo-beta-mannanase) appears on 57 US grants and 121 published applications in this corpus.
Search patents in C12N- Granted patents
- 57
- Published applications
- 121
- Assignees
- 47
- Inventors
- 258
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 2 |
| 2003 | 1 | 6 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 3 | 1 |
| 2007 | 2 | 3 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 3 | 1 |
| 2011 | 3 | 6 |
| 2012 | 1 | 5 |
| 2013 | 3 | 2 |
| 2014 | 4 | 6 |
| 2015 | 3 | 9 |
| 2016 | 2 | 4 |
| 2017 | 2 | 5 |
| 2018 | 3 | 9 |
| 2019 | 4 | 3 |
| 2020 | 3 | 5 |
| 2021 | 1 | 4 |
| 2022 | 2 | 2 |
| 2023 | 1 | 12 |
| 2024 | 3 | 14 |
| 2025 | 6 | 11 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mannanase variants and polynucleotides encoding same16 Jun 2026US 12,655,368 B2Novozymes A/S
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes19 May 2026US 12,630,484 B2Spogen Biotech Inc.
- Mannanase for formulations having pH 5-1213 Jan 2026US 12,522,813 B2BASF SE
- Mannanase variants and polynucleotides encoding same30 Dec 2025US 12,509,671 B2Novozymes A/S
- Polypeptides having mannanase activity and polynucleotides encoding same2 Dec 2025US 12,486,477 B2Novozymes A/S
- Mannanase variants and polynucleotides encoding same20 Aug 2026US 2026/0242701 A1Novozymes A/S
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes30 Jul 2026US 2026/0217621 A1Spogen Biotech Inc.
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes30 Jul 2026US 2026/0217622 A1Spogen Biotech Inc.
- Uses of Dendrobium polysaccharides and vancomycin-sensitive bacteria, and compositions containing the same23 Apr 2026US 2026/0108552 A1Hong Kong Authentication Centre of Valuable Chinese Medicines
- Composition containing partially hydrolyzed guar gum and method for preparing the same19 Mar 2026US 2026/0078204 A1Zymebase Inc.
Most cited
By later US patents
- Xylanases, nucleic acids encoding them and methods for making and using them23US 8,043,839 B2Verenium Corporation · 2011
- Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing animal feed19US 5,429,828 AChemgen Corporation · 1995
- Apoptosis inducers15US 6,207,652 B1Research Institute for Glycotechnology · 2001
- Thermal tolerant mannanase from acidothermus cellulolyticus10US 7,112,429 B2Midwest Research Institute · 2006
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes7US 11,124,460 B2Spogen Biotech Inc. · 2021